Fulgent Genetics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
990.00
4,985.00
5,388.00
2,510.00
5,607
Depreciation, Depletion & Amortization
196.00
575.00
1,170.00
1,728.00
2,163
Other Funds
-
-
1,412.00
-
3,977
Funds from Operations
4,074.00
779.00
6,262.00
2,045.00
569
Changes in Working Capital
323.00
1,748.00
1,857.00
714.00
1,244
Net Operating Cash Flow
4,397.00
969.00
4,405.00
1,331.00
675
Capital Expenditures
731.00
2,100.00
3,788.00
2,895.00
Sale of Fixed Assets & Businesses
4,000.00
3,570.00
10.00
-
Purchase/Sale of Investments
-
-
39,017.00
3,307.00
Net Investing Cash Flow
3,220.00
1,295.00
42,795.00
2,049.00
Cash Dividends Paid - Total
-
-
4,592.00
-
Net Financing Cash Flow
-
-
45,789.00
770.00
Net Change in Cash
1,177.00
326.00
7,399.00
1,407.00
Free Cash Flow
5,128.00
3,069.00
617.00
1,564.00
Deferred Taxes & Investment Tax Credit
-
-
246.00
336.00
36
Change in Capital Stock
-
-
51,793.00
770.00
Exchange Rate Effect
-
-
-
81.00
Other Uses
49.00
175.00
-
2,461.00
About Fulgent Genetics
View Profile
